The best Side of semaglutude Weeks 13-16 Bundle
The demo obtained both its Principal endpoints, with semaglutide 2.4 mg demonstrating statistically sizeable and remarkable improvements in liver fibrosis without worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH as compared to placebo.1Connect with your medical doctor right